Welcome to LookChem.com Sign In|Join Free

CAS

  • or

446-72-0

Post Buying Request

446-72-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

446-72-0 Usage

Chemical Description

Genistein and orobol are isoflavone bis-C-glycosides, while p-TsOH·H2O is para-toluenesulfonic acid monohydrate, Na2S2O3 is sodium thiosulfate, CHCl3 is chloroform, MeOH is methanol, and silica gel is a type of stationary phase used in column chromatography.

description

Genistein is one of the most abundant isoflavones in soy and is one of several known isoflavones. Isoflavones compounds, such as genistein and daidzein, are found in a number of plants, but soybeans and soy products like tofu and textured vegetable protein are the primary food source. Because of its similar structure to that of human estrogen it is also called a phytoestrogen. Genistein is a natural bioactive compound derived from legumes and has drawn because of its potentially beneficial effects on some human degenerative diseases. It has a weak estrogenic effect and is a well-known non-specific tyrosine kinase inhibitor at pharmacological doses. Genistein is a soy-derived isoflavone and phytoestrogen with antineoplastic activity. Genistein binds to and inhibits protein-tyrosine kinase, thereby disrupting signal transduction and inducing cell differentiation. This agent also inhibits topoisomerase-II, leading to DNA fragmentation and apoptosis, and induces G2/M cell cycle arrest. Genistein exhibits antioxidant, antiangiogenic, and immunosuppressive activities. In adult animals, dietary genistein has chemopreventive effects on breast, prostate, and other endocrine-dependent tumors.

Pharmacological effects

Genistein is a kind of polyphenols compound which can be found in soy and red clover and other plants with its molecular structure being similar to 17β-estradiol and having antioxidant activity and high affinity towards estrogen receptor. It can inhibit the activity of protein tyrosine kinase (PTK) and topoisomerase enzyme activity II with capability of inducing programmed cell death and improve the efficacy of anti-cancer drug as well as inhibit angiogenesis, and so on. It is one type of flavonoids (also called isoflavones) and is often found together with isoflavones called the isoflavones. They are all called soy isoflavones. Those benefits of these kinds of compounds on human health have been studied extensively and it is a promising cancer chemopreventive agent with significant impact on preventing cancer and other diseases. Genistein is the major phytoestrogens in the present study. Plant Source: legume Genista (broom). Clinical Applications: it can be used for female beauty care and prevention of blood diseases and cancer. Genistein contains polyphenol structure with the hydrogen atoms in the phenolic hydroxyl group being prone to dissociate from external oxygen atom from the external interaction, leading to the formation of hydrogen ions to play reduction effect. This is the structure basis for the capability of the genistein of anti-oxidative and reductive. So those substances in food can fight against superoxide anion radicals, blocking the chain reaction of free radicals and play a role in anti-oxidation. Genistein is not a hormone, but because it can bind to estrogen receptors and plays a weak estrogenic effect, it is called phytoestrogens. Because the activity of isoflavones is only 1/1000 of the estradiol which can competitively bind with estrogen receptors, exhibiting two-way adjustment with the resulting estrogenic effects of much lower harmful effects than estradiol and further with protective effect on then hormone related diseases such as menopause, osteoporosis, elevated blood lipids, etc; for patients of high levels of estrogen, it exhibits anti-estrogenic activity and can prevent breast cancer, endometriosis with two-way balance adjustment function. Genistein, for the rat high cholesterol induced by TNT (trinitrotoluene) WR1339, has effect of lowering serum cholesterol and triglycerides with the effect on the later one being particularly significant. This information is edited by Xiongfeng Dai from lookchem.

Physical and Chemical Properties

It appears as pale yellow dendritic needle-like powder with the melting point being 297 ℃-298 ℃; It is soluble in common organic solvents but almost insoluble in water. When being dissolved in dilute alkali, it will become yellow color.

Uses

Different sources of media describe the Uses of 446-72-0 differently. You can refer to the following data:
1. It has anti-tumor, anti-fungal, blood lipid-lowering and can fight against estrogen activity.
2. genistein is an isoflavone commonly found in soy. It has demonstrated uV-protection properties through anti-oxidant activity. Studies indicate genistein can promote collagen synthesis, making it applicable in anti-aging cosmetics.
3. Exhibits specific inhibitory activity against tyrosine kinases,including autophosphorylation of epidermal growth factor receptor kinase (IC50 - 2.6uM). Also inhibits other protein kinases through competitive inhibition of ATP. Inhibits tumor cell proliferation and induces tumor cell differentiation. Produces cell-cycle arrest and apoptosis in Jurat T-leukemia cells. However, it prevents anti-CD3 monoclonal antibody-induced thymic apoptosis. Genistein also inhibits topoisomerase II activity in vitro. Genistein has also been shown to inhibit the action of GABA on recombinant GABAA receptors 2. uv(max)ethanol: 262.5 nm (e= 138). moderately sol. in hot alcohol
4. Genistein, a phytoestrogen found in soy products, is a highly specific inhibitor of protein tyrosine kinase (PTK) which blocks the mitogenic effect mediated by EGF on NIH-3T3 cells with IC50 of 12μM or by insulin with IC50 of 19 μM.
5. cytotoxic inhibitor of tyrosine kinase and topoisomerase II kinase

Mechanism of action

Different sources of media describe the Mechanism of action of 446-72-0 differently. You can refer to the following data:
1. Genistein may inhibit cancer cell growth by blocking enzymes required for cell growth. Genistein may decrease cardiovascular risk in postmenopausal women by interacting with the nuclear estrogen receptors to alter the transcription of cell specific genes. In randomized clinical trials, genistein was seen to increase the ratio of nitric oxide to endothelin and improved flow-mediated endothelium dependent vasodilation in healthy postmenopausal women. In addition, genistein may have beneficial effects on glucose metabolism by inhibiting islet tyrosine kinase activity as well as insulin release dependent on glucose and sulfonylurea. References https://www.drugbank.ca/drugs/DB01645
2. Genistein, an isoflavone isolated from soybeans, exhibits anticarcinogenic and antioxidant properties. Particularly, genistein has been shown to inhibit production of IL-6 and MAPK. Modulation to these cellular events may help regulate and attenuate UVB-induced inflammatory damage to the skin. Moreover, genistein inhibits UV-induced oxidative DNA damage and blocks UV-induced expression of c-fos and c-jun proto-oncogenes.

Health Benefits

Estrogenic effect The estrogenic activity of genistein has been confirmed in many studies. Of all the isoflavones, genistein has the strongest estrogenic activity. The estrogenic effect of genistein may explain its protective action against osteoporosis and its possible effect on body weight reductions. Genistein is also used to ease menopause symptoms, such as hot flushes. Antioxidant Genistein is a strong antioxidant. Genistein removes damaging free radicals and reduces lipid peroxidation. Genistein increases the activity of other antioxidant enzymes such as glutathione peroxidase, superoxide dismutase and glutathione reductase. Studies have shown that genistein can also influence the growth of cells which are not hormone-dependent. Anticancer Genistein seems to reduce the risk for some hormone related cancers, principally breast cancer and prostate cancer. Epidemiological studies show that consumption of isoflavones may protect against breast and prostate cancer. High dietary intake of soy products China and Japan are linked with low incidence of these cancers. There are lots of theories to explain the anti-cancer action of genistein: inhibition of angiogenesis, inhibition of tyrosine kinases, antioxidant property, and anti-estrogen action (it is known that estrogen increases risk for certain cancers). Genistein binds with estrogen receptors, preventing the estrogen from binding and initiating cancer growth. Heart health Many in-vitro tests have demonstrated that genistein inhibits cellular cholesterol synthesis and cholesterol esterification. Genistein also reduces fatty acid oxidation and exerts lipid lowering effect. Only oxidized LDL cholesterol is absorbed by the arterial cells and prevention of this oxidation will reduce the risk for arteriosclerosis. Gensistein prevents the formation of hearth attacks and strokes by acting as anticlotting agent. References http://www.phytochemicals.info/phytochemicals/genistein.php

Description

Genistein (446-72-0) is a naturally occurring flavonoid with a wide range of biological actions. Inhibits protein tyrosine kinases including epidermal growth factor receptor kinase.1,2?Phytoestrogen3?and agonist at GPR304. Displays cancer chemopreventive activity.5

Chemical Properties

Yellow Crystalline Solid

Definition

ChEBI: 7-Hydroxyisoflavone with additional hydroxy groups at positions 5 and 4'. It is a phytoestrogenic isoflavone with antioxidant properties.

General Description

Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards

Biological Activity

Phytoestrogen with a wide range of biological actions. Inhibits protein tyrosine kinases including epidermal growth factor receptor kinase. Also binds to PPAR γ and estrogen receptors and acts as an agonist at GPR30. Also available as part of the MAPK Cascade Inhibitor Tocriset? .

Biochem/physiol Actions

Inhibitor of tyrosine protein kinase; competitive inhibitor of ATP in other protein kinase reactions. Antiangiogenic agent, down-regulates the transcription of genes involved in controlling angiogenesis.

Anticancer Research

It is an isoflavone and is obtained from a variety of plants like psoralea (Psoraleacorylifolia), kudzu (Pueraria lobata), faba beans (Vicia faba), and soybeans(Glycine max). It exhibits anticancer effect by inhibiting NF-κB and protein kinaseB (Akt) signaling pathways (Singh et al. 2016b). It blocks the proliferation of cancercells via the inhibition of cell growth enzymes and survival like tyrosine kinase andtopoisomerase II; hence it is used to treat leukemia. Genistein increases the growthrate of some estrogen receptors in breast cancer cells and the rate of proliferation of estrogen-dependent breast cancer by competitive binding to the estrogen-β receptors.It may be involved in JNK pathway in inducing activator protein-1(AP-1) activity(Wang et al. 2012; Dixon and Ferreira 2002).

Safety Profile

Experimental reproductive effects. Human mutation data reported. When heated to decomposition it emits acrid smoke and irritating fumes.

Purification Methods

Crystallise it from EtOH or aqueous EtOH. It has UV: max at 290nm (EtOH). The S(-)-enantiomer (natural form) has m 255-256o (from EtOH) and [] D 20 -28.0o (c 2, EtOH), [ ] D 20 -35.2o (c 1, pyridine).[Beilstein 18 H 503, 18 II 164, 18 III/IV 2630.] Genistein (4',5,7-trihydroxyisoflavone) [446-72-0]M 270.2 crystallises from 60% aqueous EtOH or water with m 297-298o and [] D 20 -28o (c 0.6, 20mM NaOH). [Beilstein 18/4 V 594.]For Naringin (naringenin 7-rhamnoglucoside) See “Carbohydrates” in Chapter 6.

References

1) Akiyama?et al.?(1987),?Genistein, a specific inhibitor of tyrosine-specific protein kinases; J. Biol. Chem.,?262?5592 2) Linassier?et al.?(1990),?Mechanisms of action in NIH-3T3 cells of genistein, an inhibitor if EGF receptor tyrosine kinase?Biochem. Pharmacol.,?39?187 3) Dang?et al.?(2003),?Peroxisome proliferator-activated receptor gamma (PPARgamma) as a molecular target for the soy phytoestrogen genistein; J. Biol. Chem.,?278?962 4) Vivacqua?et al.?(2006),?17beta-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the g protein-coupled receptor GPR30; Mol. Pharmacol., 70?1414 5) Sarker and Li (2002),?Mechanisms of cancer chemoprevention by soy isoflavone genistein; Cancer Metastasis Rev.,?21?265

Check Digit Verification of cas no

The CAS Registry Mumber 446-72-0 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 4,4 and 6 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 446-72:
(5*4)+(4*4)+(3*6)+(2*7)+(1*2)=70
70 % 10 = 0
So 446-72-0 is a valid CAS Registry Number.
InChI:InChI=1/C15H10O5/c16-9-3-1-8(2-4-9)11-7-20-13-6-10(17)5-12(18)14(13)15(11)19/h1-7,16-18H

446-72-0 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (G0272)  Genistein  >98.0%(HPLC)

  • 446-72-0

  • 100mg

  • 122.00CNY

  • Detail
  • TCI America

  • (G0272)  Genistein  >98.0%(HPLC)

  • 446-72-0

  • 1g

  • 330.00CNY

  • Detail
  • USP

  • (1288816)  Genistein  United States Pharmacopeia (USP) Reference Standard

  • 446-72-0

  • 1288816-15MG

  • 4,662.45CNY

  • Detail
  • Sigma-Aldrich

  • (92136)  Genistein  analytical standard

  • 446-72-0

  • 92136-10MG

  • 1,964.43CNY

  • Detail
  • Sigma-Aldrich

  • (05360590)  Genistein  primary pharmaceutical reference standard

  • 446-72-0

  • 05360590-50MG

  • 5,933.07CNY

  • Detail
  • Sigma

  • (G6649)  Genistein  synthetic, ≥98% (HPLC), powder

  • 446-72-0

  • G6649-5MG

  • 402.48CNY

  • Detail
  • Sigma

  • (G6649)  Genistein  synthetic, ≥98% (HPLC), powder

  • 446-72-0

  • G6649-25MG

  • 1,193.40CNY

  • Detail
  • Sigma

  • (G6649)  Genistein  synthetic, ≥98% (HPLC), powder

  • 446-72-0

  • G6649-100MG

  • 3,616.47CNY

  • Detail
  • Sigma

  • (G6776)  Genistein  from Glycine max (soybean), ~98% (HPLC)

  • 446-72-0

  • G6776-5MG

  • 752.31CNY

  • Detail
  • Sigma

  • (G6776)  Genistein  from Glycine max (soybean), ~98% (HPLC)

  • 446-72-0

  • G6776-10MG

  • 1,301.04CNY

  • Detail

446-72-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name Genistein

1.2 Other means of identification

Product number -
Other names 5,7,4'-trihydroxyisoflavone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:446-72-0 SDS

446-72-0Synthetic route

genistin
529-59-9

genistin

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

Conditions
ConditionsYield
β-glucosidase, derived from Aspergillus niger In methanol at 55℃; for 6h; pH=4; Enzyme kinetics; Aqueous acetate buffer;100%
In hydrogenchloride99%
β-glucosidase, derived from almond In methanol at 55℃; for 6h; pH=4; Enzyme kinetics; Aqueous acetate buffer;11.8%
genistein-7-O-β-D-(6''-O-acetylglucopyranoside)
73566-30-0

genistein-7-O-β-D-(6''-O-acetylglucopyranoside)

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

Conditions
ConditionsYield
diglycosidase, produced by Penicillium multicolor IAM7153 In methanol at 55℃; for 3h; pH=4; Enzyme kinetics; Aqueous acetate buffer;99.9%
diglycosidase, produced by Aspergillus fumigatus IAM2046 In methanol at 55℃; for 6h; pH=4; Enzyme kinetics; Aqueous acetate buffer;35.2%
β-glucosidase, derived from Aspergillus niger In methanol at 55℃; for 6h; pH=4; Enzyme kinetics; Aqueous acetate buffer;6.2%
β-xylosidase, derived from pectinase G In methanol at 55℃; for 6h; pH=4; Enzyme kinetics; Aqueous acetate buffer;0.5%
sulfur trioxide N,N-dimethylformamide complex

sulfur trioxide N,N-dimethylformamide complex

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

Conditions
ConditionsYield
Stage #1: 2,4,4',6-tetrahydroxydeoxybenzoin With sodium carbonate In N,N-dimethyl-formamide at 25℃; for 3h;
Stage #2: sulfur trioxide N,N-dimethylformamide complex In N,N-dimethyl-formamide at 0 - 80℃; for 18.5h;
Stage #3: With sulfuric acid; water In N,N-dimethyl-formamide for 0.666667h; Product distribution / selectivity;
95%
2,4,4',6-tetrahydroxydeoxybenzoin
15485-65-1

2,4,4',6-tetrahydroxydeoxybenzoin

sodium formate
141-53-7

sodium formate

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

Conditions
ConditionsYield
Stage #1: 2,4,4',6-tetrahydroxydeoxybenzoin; sodium formate With propionyl chloride In acetone at 21 - 32℃; for 1h;
Stage #2: With triethylamine In acetone at 20 - 32℃; for 2.5h;
Stage #3: With sulfuric acid; water In acetone at 20℃; for 16h; Product distribution / selectivity;
94.8%
Stage #1: 2,4,4',6-tetrahydroxydeoxybenzoin; sodium formate With acetyl chloride In acetone at 12 - 25℃; for 2h;
Stage #2: With triethylamine In acetone at 18 - 32℃; for 3h;
Stage #3: With sulfuric acid; water In acetone at 20℃; for 16h; Product distribution / selectivity;
91.7%
Stage #1: 2,4,4',6-tetrahydroxydeoxybenzoin; sodium formate With isobutyryl chloride In acetone at 21 - 32℃; for 2h;
Stage #2: With triethylamine In acetone at 18 - 32℃; for 2.5h;
Stage #3: With sulfuric acid; water In acetone at 20℃; for 16h; Product distribution / selectivity;
90.2%
2,4,4',6-tetrahydroxydeoxybenzoin
15485-65-1

2,4,4',6-tetrahydroxydeoxybenzoin

sodium formate
141-53-7

sodium formate

propionyl chloride
79-03-8

propionyl chloride

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

Conditions
ConditionsYield
Stage #1: sodium formate; propionyl chloride In acetone at 21 - 35℃; for 3h;
Stage #2: 2,4,4',6-tetrahydroxydeoxybenzoin With triethylamine In acetone at 20 - 22℃; for 2h;
Stage #3: With sulfuric acid; water In acetone at 20℃; for 16h;
93%
Stage #1: 2,4,4',6-tetrahydroxydeoxybenzoin; sodium formate; propionyl chloride In acetone at 21 - 35℃; for 2h;
Stage #2: With triethylamine In acetone at 18 - 35℃; for 3h;
Stage #3: With sulfuric acid; water In acetone at 60 - 70℃; for 1.5h;
92.2%
Stage #1: 2,4,4',6-tetrahydroxydeoxybenzoin; sodium formate; propionyl chloride In formic acid ethyl ester at 23 - 35℃; for 3h;
Stage #2: With triethylamine In formic acid ethyl ester at 18 - 22℃; for 16h;
Stage #3: With sulfuric acid; water In formic acid ethyl ester at 80℃;
92.7%
3-(4-hydroxyphenyl)-5,7-bis(methoxymethoxy)-4H-1-benzopyran-4-one
1236208-91-5

3-(4-hydroxyphenyl)-5,7-bis(methoxymethoxy)-4H-1-benzopyran-4-one

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

Conditions
ConditionsYield
With hydrogenchloride; water In methanol; chloroform for 1h; Reflux;92%
2,4,4',6-tetrahydroxydeoxybenzoin
15485-65-1

2,4,4',6-tetrahydroxydeoxybenzoin

sodium formate
141-53-7

sodium formate

isobutyryl chloride
79-30-1

isobutyryl chloride

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

Conditions
ConditionsYield
Stage #1: 2,4,4',6-tetrahydroxydeoxybenzoin; sodium formate; isobutyryl chloride In acetone at 21 - 32℃; for 3h;
Stage #2: With triethylamine In acetone at 18 - 32℃; for 2h;
Stage #3: With sulfuric acid; water In acetone at 60 - 70℃; for 3h;
90.3%
2,4,4',6-tetrahydroxydeoxybenzoin
15485-65-1

2,4,4',6-tetrahydroxydeoxybenzoin

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

Conditions
ConditionsYield
With boron trifluoride diethyl etherate; methanesulfonyl chloride In N,N-dimethyl-formamide at 50℃; for 12h; Molecular sieve;90%
With methanesulfonyl chloride In N,N-dimethyl-formamide at 60 - 70℃; for 1h;53%
Multi-step reaction with 2 steps
1: pyridine / Behandeln des Reaktionsprodukts mit wss. Natronlauge
2: 325 °C
View Scheme
2,4,4',6-tetrahydroxydeoxybenzoin
15485-65-1

2,4,4',6-tetrahydroxydeoxybenzoin

N,N-dimethyl-formamide
68-12-2, 33513-42-7

N,N-dimethyl-formamide

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

Conditions
ConditionsYield
Stage #1: N,N-dimethyl-formamide With phosphorus pentachloride at 55℃; for 0.333333h; Chlorination;
Stage #2: 2,4,4',6-tetrahydroxydeoxybenzoin With boron trifluoride diethyl etherate In N,N-dimethyl-formamide at 20℃; for 1h; Cycloaddition;
90%
Stage #1: 2,4,4',6-tetrahydroxydeoxybenzoin With boron trifluoride diethyl etherate In N,N-dimethyl-formamide at 50 - 60℃; Cooling with ice;
Stage #2: N,N-dimethyl-formamide With methanesulfonyl chloride at 50 - 70℃;
84%
With boron trifluoride diethyl etherate; methanesulfonyl chloride 1.) irradiation, reflux, 15 s, 2.) irradiation, reflux, 1 min; Yield given. Multistep reaction;
With phosphorus pentachloride; boron trifluoride diethyl etherate at 20℃; for 1h; Cyclization;
With boron trifluoride diethyl etherate; methanesulfonyl chloride at 50 - 100℃;
[5-hydroxy-3-(4-hydroxyphenyl)-4-oxochromen-7-yl]dihydrogen phosphate

[5-hydroxy-3-(4-hydroxyphenyl)-4-oxochromen-7-yl]dihydrogen phosphate

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

Conditions
ConditionsYield
With sulfatase VIII In water at 37℃; for 0.5h; pH=5.2;89%
formic acid
64-18-6

formic acid

2,4,4',6-tetrahydroxydeoxybenzoin
15485-65-1

2,4,4',6-tetrahydroxydeoxybenzoin

propionic acid anhydride
123-62-6

propionic acid anhydride

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

Conditions
ConditionsYield
Stage #1: formic acid; propionic acid anhydride at 25 - 45℃; for 2h;
Stage #2: 2,4,4',6-tetrahydroxydeoxybenzoin With triethylamine In acetone at 20 - 40℃; for 19h;
Stage #3: With sulfuric acid; water In acetone at 60℃;
86.5%
Stage #1: formic acid; 2,4,4',6-tetrahydroxydeoxybenzoin; propionic acid anhydride at 25 - 45℃; for 2h;
Stage #2: With triethylamine at 20 - 40℃; for 19h;
Stage #3: With sulfuric acid; water at 75℃; for 2.5h;
82.5%
5,7-Dihydroxy-3-(4-methoxy-phenyl)-chromen-4-on
491-80-5

5,7-Dihydroxy-3-(4-methoxy-phenyl)-chromen-4-on

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

Conditions
ConditionsYield
With aluminum (III) chloride In toluene at 140℃; for 6h;84%
With aluminium trichloride In benzene for 18h; Heating;47%
With hydrogen iodide
2,4,4',6-tetrahydroxydeoxybenzoin
15485-65-1

2,4,4',6-tetrahydroxydeoxybenzoin

Propionic formic anhydride
10500-31-9

Propionic formic anhydride

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

Conditions
ConditionsYield
Stage #1: 2,4,4',6-tetrahydroxydeoxybenzoin; Propionic formic anhydride With triethylamine In acetone at 25 - 40℃; for 3h;
Stage #2: With sulfuric acid; water In acetone at 20 - 60℃;
84%
6''-O-malonylgenistin
51011-05-3

6''-O-malonylgenistin

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

Conditions
ConditionsYield
diglycosidase, produced by Penicillium multicolor IAM7153 In methanol at 55℃; for 6h; pH=4; Enzyme kinetics; Aqueous acetate buffer;82.3%
β-glucosidase, derived from Aspergillus niger In methanol at 55℃; for 6h; pH=4; Enzyme kinetics; Aqueous acetate buffer;12.1%
diglycosidase, produced by Aspergillus fumigatus IAM2046 In methanol at 55℃; for 6h; pH=4; Enzyme kinetics; Aqueous acetate buffer;8.2%
β-xylosidase, derived from pectinase G In methanol at 55℃; for 6h; pH=4; Enzyme kinetics; Aqueous acetate buffer;2%
With Dalbergia nigrescens β-glucosidase In acetate buffer; dimethyl sulfoxide at 37℃; for 0.166667h; pH=5.5; Enzyme kinetics; Further Variations:; Reagents;
formic acid
64-18-6

formic acid

2,4,4',6-tetrahydroxydeoxybenzoin
15485-65-1

2,4,4',6-tetrahydroxydeoxybenzoin

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

Conditions
ConditionsYield
Stage #1: formic acid; 2,4,4',6-tetrahydroxydeoxybenzoin With acetic anhydride; triethylamine at 20℃; for 24h; Industrial scale;
Stage #2: With hydrogenchloride; water In methanol at 20℃; for 22h; Industrial scale;
79.5%
1,3,5-Triazine
290-87-9

1,3,5-Triazine

2,4,4',6-tetrahydroxydeoxybenzoin
15485-65-1

2,4,4',6-tetrahydroxydeoxybenzoin

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

Conditions
ConditionsYield
With boron trifluoride diethyl etherate; acetic anhydride In diethyl ether; acetic acid Heating;78%
2-bromo-1-(4'-hydroxyphenyl)-1-ethanone
2491-38-5

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone

2,4,6-trihydroxybenzaldehyde
487-70-7

2,4,6-trihydroxybenzaldehyde

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

Conditions
ConditionsYield
Stage #1: 2-bromo-1-(4'-hydroxyphenyl)-1-ethanone With thiamine hydrochloride In ethanol at 20℃; for 0.25h; Green chemistry;
Stage #2: 2,4,6-trihydroxybenzaldehyde In ethanol at 20℃; for 1.58333h; Green chemistry;
75%
2,4,4',6-tetrahydroxydeoxybenzoin
15485-65-1

2,4,4',6-tetrahydroxydeoxybenzoin

sodium formate
141-53-7

sodium formate

benzoyl chloride
98-88-4

benzoyl chloride

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

Conditions
ConditionsYield
Stage #1: sodium formate; benzoyl chloride In acetone at 21 - 40℃; for 3h;
Stage #2: 2,4,4',6-tetrahydroxydeoxybenzoin With triethylamine In acetone at 21 - 35℃; for 3h;
Stage #3: With sulfuric acid; water In acetone at 20℃; for 16h;
52.7%
5,7-dihydroxy-3-(4-hydroxy-phenyl)-4-oxo-4H-chromene-2-carboxylic acid
22151-32-2

5,7-dihydroxy-3-(4-hydroxy-phenyl)-4-oxo-4H-chromene-2-carboxylic acid

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

Conditions
ConditionsYield
at 325℃;
7-((2S,3R,4R)-3,4-Dihydroxy-4-hydroxymethyl-tetrahydro-furan-2-yloxy)-3-[4-((2R,3S,4S)-3,4-dihydroxy-4-hydroxymethyl-tetrahydro-furan-2-yloxy)-phenyl]-5-hydroxy-chromen-4-one
78694-77-6

7-((2S,3R,4R)-3,4-Dihydroxy-4-hydroxymethyl-tetrahydro-furan-2-yloxy)-3-[4-((2R,3S,4S)-3,4-dihydroxy-4-hydroxymethyl-tetrahydro-furan-2-yloxy)-phenyl]-5-hydroxy-chromen-4-one

B

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

Conditions
ConditionsYield
With sulfuric acid Heating;
5-O-β-D-glucopyranosylgenistein
128508-06-5

5-O-β-D-glucopyranosylgenistein

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

Conditions
ConditionsYield
With malic acid at 60℃; other object of study: half-lives; other reagent : acetic acid, oxalic acid, HCl; other temperature;
4′,7-dihydroxy-8β-D-glucose isoflavone
66026-80-0

4′,7-dihydroxy-8β-D-glucose isoflavone

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

Conditions
ConditionsYield
With hydrogen iodide; phenol at 135℃; for 7h; Heating;25 mg
6,8-di-C-β-D-glucopyranosyl-4',5,7-trihydroxyisoflavone
32361-88-9

6,8-di-C-β-D-glucopyranosyl-4',5,7-trihydroxyisoflavone

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

Conditions
ConditionsYield
With hydrogen iodide; phenol Heating;20 mg
1-(2-acetoxy-4,6-dihydroxyphenyl)-3,3-dimethoxy-2-(4-hydroxyphenyl)propan-1-one
148356-61-0

1-(2-acetoxy-4,6-dihydroxyphenyl)-3,3-dimethoxy-2-(4-hydroxyphenyl)propan-1-one

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

Conditions
ConditionsYield
With hydrogenchloride In methanol for 2h; Heating; Yield given;
genistein 7-O-(2

genistein 7-O-(2"-p-coumaroyl-β-D-glucopyranoside)

A

D-Glucose
2280-44-6

D-Glucose

B

p-Coumaric Acid
7400-08-0

p-Coumaric Acid

C

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

Conditions
ConditionsYield
With hydrogenchloride In methanol Heating;
sophoricoside
152-95-4

sophoricoside

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

Conditions
ConditionsYield
With water Hydrolysis; Acid hydrolysis;
5.7.4'-trimethoxy-isoflavone

5.7.4'-trimethoxy-isoflavone

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

Conditions
ConditionsYield
With hydrogen iodide; acetic anhydride; acetic acid
genisteine-7-methyl ether

genisteine-7-methyl ether

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

Conditions
ConditionsYield
With hydrogen iodide at 130℃;
5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

benzenesulfonyl chloride
98-09-9

benzenesulfonyl chloride

3-(4-benzenesulfonyloxyphenyl)-5,7-bis(benzenesulfonyloxy)-4H-chromen-4-one
1041727-57-4

3-(4-benzenesulfonyloxyphenyl)-5,7-bis(benzenesulfonyloxy)-4H-chromen-4-one

Conditions
ConditionsYield
With pyridine at -20℃; for 3h; Inert atmosphere;99%
5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

acryloyl chloride
814-68-6

acryloyl chloride

C21H14O7

C21H14O7

Conditions
ConditionsYield
With triethylamine In acetone at 20℃; for 24h;98.6%
5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

acetic anhydride
108-24-7

acetic anhydride

4',5,7-Triacetoxyisoflavone
5995-97-1

4',5,7-Triacetoxyisoflavone

Conditions
ConditionsYield
With pyridine Reflux;98%
With pyridine at 70℃; for 6h;96%
With pyridine In chloroform at 20℃; for 8h; Inert atmosphere;93%
for 6h; Heating;53%
Acetylation;
5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

Stearoyl chloride
112-76-5

Stearoyl chloride

genistein-4',7-distearate

genistein-4',7-distearate

Conditions
ConditionsYield
With potassium tert-butylate In N,N-dimethyl-formamide at 30℃; for 2.5h; Etherification;96%
5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

7,5,4’-trihydroxy-3’-nitroisoflavone

7,5,4’-trihydroxy-3’-nitroisoflavone

Conditions
ConditionsYield
With ammonium nitrate; trifluoroacetic anhydride In acetonitrile at 20℃; for 1.5h;96%
(Z)-9-octadecenoyl chloride
112-77-6

(Z)-9-octadecenoyl chloride

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

genistein-4',7-dioleate

genistein-4',7-dioleate

Conditions
ConditionsYield
With potassium tert-butylate In N,N-dimethyl-formamide at 30℃; for 2.5h; Etherification;95%
5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

methyl iodide
74-88-4

methyl iodide

4',5,7-trimethoxyisoflavone
1162-82-9

4',5,7-trimethoxyisoflavone

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 40℃; for 4h;95%
With potassium carbonate In acetone at 60℃;95%
With potassium carbonate In acetone at 50℃; for 3h; sonication;85%
5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

1-deoxy-1-fluoro-α-D-glucose
2106-10-7

1-deoxy-1-fluoro-α-D-glucose

genistein 7-α-O-glucoside

genistein 7-α-O-glucoside

Conditions
ConditionsYield
With α-glucosidase from sulfolobus solfataricus In dimethyl sulfoxide at 45℃; for 2h; pH=9; Enzymatic reaction;95%
5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

acetic anhydride
108-24-7

acetic anhydride

4-(7-acetoxy-5-hydroxy-4-oxo-4H-chromen-3-yl)phenyl acetate
65388-04-7

4-(7-acetoxy-5-hydroxy-4-oxo-4H-chromen-3-yl)phenyl acetate

Conditions
ConditionsYield
In pyridine at 20℃; for 24h;92%
In pyridine at 20℃; for 24h;92%
With pyridine at 20℃; for 24h;92%
5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

Hexanoyl chloride
142-61-0

Hexanoyl chloride

5,7,4'-tri-O-hexanoyl-genistein
918158-57-3

5,7,4'-tri-O-hexanoyl-genistein

Conditions
ConditionsYield
With pyridine; dmap91%
With pyridine; dmap In chloroform at 20℃; for 9h; Inert atmosphere;91%
With dmap; triethylamine In N,N-dimethyl-formamide at 20℃; for 4.5h; Cooling with ice;81%
With pyridine at 0 - 20℃; for 18h;
5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

A

dihydrogenistein
21554-71-2

dihydrogenistein

(3S,4R)-3-(4-Hydroxy-phenyl)-chroman-4,5,7-triol
124093-22-7

(3S,4R)-3-(4-Hydroxy-phenyl)-chroman-4,5,7-triol

Conditions
ConditionsYield
With ammonium formate; palladium on activated charcoal In methanol Ambient temperature;A 90%
B n/a
With ammonium formate; palladium on activated charcoal In methanol for 2h; Heating;A 59%
B 21%
5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

1,3-dibromo-propane
109-64-8

1,3-dibromo-propane

4',5,7-tri(3-bromopropoxy)isoflavone
862255-04-7

4',5,7-tri(3-bromopropoxy)isoflavone

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 40℃; for 1.5h; sonication;90%
With potassium carbonate In N,N-dimethyl-formamide at 60℃; for 4.75h;
5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

benzenesulfonyl chloride
98-09-9

benzenesulfonyl chloride

3-(4-hydroxyphenyl)-7-benzenesulfonyloxy-5-hydroxy-4H-chromen-4-one
1041727-51-8

3-(4-hydroxyphenyl)-7-benzenesulfonyloxy-5-hydroxy-4H-chromen-4-one

Conditions
ConditionsYield
With pyridine In tetrahydrofuran at -20℃; for 0.333333h; Inert atmosphere;90%
5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

tetra(n-butyl)ammonium hydroxide
2052-49-5

tetra(n-butyl)ammonium hydroxide

tetra n-butylammonium salt of genistein

tetra n-butylammonium salt of genistein

Conditions
ConditionsYield
In methanol; water at 20℃;89%
5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

ethylene dibromide
106-93-4

ethylene dibromide

7-(2-bromoethoxy)-5-hydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one
862255-00-3

7-(2-bromoethoxy)-5-hydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide sonication;88%
With potassium carbonate In N,N-dimethyl-formamide at 40℃; for 1.5h; sonication;86%
With sodium hydrogencarbonate In acetone at 65℃; for 24h;71%
5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

acetic anhydride
108-24-7

acetic anhydride

A

4-(7-acetoxy-5-hydroxy-4-oxo-4H-chromen-3-yl)phenyl acetate
65388-04-7

4-(7-acetoxy-5-hydroxy-4-oxo-4H-chromen-3-yl)phenyl acetate

B

7-acetoxy-4',5-dihydroxygenistein

7-acetoxy-4',5-dihydroxygenistein

Conditions
ConditionsYield
With pyridine for 7h; Reflux;A 87.2%
B 5.3%
(Z)-9-octadecenoyl chloride
112-77-6

(Z)-9-octadecenoyl chloride

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

genistein-7-monooleate

genistein-7-monooleate

Conditions
ConditionsYield
With potassium tert-butylate In N,N-dimethyl-formamide at 30℃; for 2.5h; Etherification;87%
5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

1,3-dibromo-propane
109-64-8

1,3-dibromo-propane

7-(3-bromopropoxy)-5-hydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one
862255-02-5

7-(3-bromopropoxy)-5-hydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide sonication;87%
With potassium carbonate In N,N-dimethyl-formamide at 40℃; for 1.5h; sonication;85%
With sodium hydrogencarbonate; potassium carbonate In acetone at 65℃; for 8h;78.47%
5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

chloromethyl methyl ether
107-30-2

chloromethyl methyl ether

5,7,4'-trimethoxymethoxyisoflavone

5,7,4'-trimethoxymethoxyisoflavone

Conditions
ConditionsYield
With sodium hydride In N,N-dimethyl-formamide at 0 - 20℃; for 2h;87%
With sodium hydride In N,N-dimethyl-formamide; mineral oil at 0 - 20℃; for 2h;87%

446-72-0Relevant articles and documents

Hydrolysis of soybean isoflavonoid glycosides by Dalbergia β-glucosidases

Chuankhayan, Phimonphan,Rimlumduan, Thipwarin,Svasti, Jisnuson,Ketudat Cairns, James R.

, p. 2407 - 2412 (2007)

Two β-glucosidases from the legumes Dalbergia cochinchinensis and Dalbergia nigrescens were compared for their ability to hydrolyze isoflavonoid glycosides from soybean. Both D. nigrescens and D. cochinchinensis β-glucosidases could hydrolyze conjugated soybean glycosides, but D. nigrescens β-glucosidase hydrolyzed both conjugated and nonconjugated glycosides in crude soybean extract more rapidly. The kinetic properties K m, kcat, and kcat/Km of the Dalbergia β-glucosidases toward conjugated isoflavonoid glycosides, determined using high-performance liquid chromatography, confirmed the higher efficiency of the D. nigrescens β-glucosidase in hydrolyzing these substrates. The D. nigrescens β-glucosidase could also efficiently hydrolyze isoflavone glycosides in soy flour suspensions, suggesting its application to increase free isoflavones in soy products.

Deglycosylation of isoflavonoid glycosides from maackia amurensis cell culture by β-D-glucosidase from littorina sitkana hepatopancrease

Kusaikin,Zakharenko,Ermakova,Veselova,Grigoruk,Fedoreev,Zvyagintseva

, p. 197 - 200 (2011)

Maakia amurensis (strain A-18) cell culture synthesizes a significant quantity of isoflavonoids, a large part of which consists of isoflavone glucosides and malonylglucosides. β-D-Hydrolase enzyme complexes from the marine mollusk Littorina sitkana and the marine mycelial fungus P. canescens were used to obtain isoflavones from their conjugated forms. The specificity of β-D-glucanases from L. sitkana for various glycosides was studied. The deglycosylation efficiency depended on the aglycon structure. The deglycosylated fraction of isoflavonoids obtained from M. amurensis cell culture exhibited antitumor activity.

-

Kathsev,Nikonov

, (1972)

-

-

Zapesochnaya,Laman

, (1977)

-

First finding of Daidzein 7-O-phosphate and Genistein 7-O-phosphate that are hydrolyzed by sulfatase

Kanakubo, Akira,Koga, Kazushi,Isobe, Minoru,Fushimi, Tatsushi,Saitoh, Takanobu,Ohshima, Yoshifumi,Tsukamoto, Yoshinori

, p. 8801 - 8805 (2001)

Attempted structural assignment of two water soluble isoflavone analogs of Daidzein and Genistein, was initially assumed to be the corresponding sulfates on the basis of the facts that these analogs were hydrolyzed by sulfatase; however, they were eventua

Identification of ortho catechol-containing isoflavone as a privileged scaffold that directly prevents the aggregation of both amyloid β plaques and tau-mediated neurofibrillary tangles and its in vivo evaluation

Do, Ji Min,Gee, Min Sung,Inn, Kyung-Soo,Kim, Jong-Ho,Kim, Nam Kwon,Kim, Nam-Jung,Lee, Hyun Woo,Lee, Jong Kil,Seo, Min-Duk,Seong, Ji Hye,Son, Seung Hwan,Yoo, Hyung-Seok,Yoo, Ji-Na

, (2021/07/01)

In this study, polyhydroxyisoflavones that directly prevent the aggregation of both amyloid β (Aβ) and tau were expediently synthesized via divergent Pd(0)-catalyzed Suzuki-Miyaura coupling and then biologically evaluated. By preliminary structure–activity relationship studies using thioflavin T (ThT) assays, an ortho-catechol containing isoflavone scaffold was proven to be crucial for preventing both Aβ aggregation and tau-mediated neurofibrillary tangle formation. Additional TEM experiment confirmed that ortho-catechol containing isoflavone 4d significantly prevented the aggregation of both Aβ and tau. To investigate the mode of action (MOA) of 4d, which possesses an ortho-catechol moiety, 1H-15N HSQC NMR analysis was thoroughly performed and the result indicated that 4d could directly inhibit both the formation of Aβ42 fibrils and the formation of tau-derived neurofibrils, probably through the catechol-mediated nucleation of tau. Finally, 4d was demonstrated to alleviate cognitive impairment and pathologies related to Alzheimer's disease in a 5XFAD transgenic mouse model.

Synthesis, Characterization, and Antioxidant Activities of Genistein, Biochanin A, and Their Analogues

Hamza Sherif, Salah,Gebreyohannes, BerihuTekluu

, (2018/04/30)

A series of naturally occurring genistein (3) and biochanin A (4) compounds and their analogues were synthesized from phloroglucinol. The structures of all the synthesized compounds were established by the combined use of 1HNMR, 13CNMR, IR spectral data, and mass spectrometry; their antioxidant activities were investigated. Most of the synthesized compounds show moderate-to-high activity; only two compounds exhibit no significant activity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 446-72-0